RiboX Therapeutics

RiboX | Circular RNA

Shanghai, China · Founded 2021 · $110.0M raised

Headquarters
Shanghai
Founded
2021
Business Model
B2B
Total Funding
$110.0M
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 3 investors for this company. The full record is or through the API.

About

RiboX Therapeutics is a biotechnology company discovering and developing fully engineered circular RNA (circRNA) therapeutics, a class of RNA medicines designed to overcome the stability and durability limitations of conventional mRNA drugs. Cofounded in 2021 by Drs. Ling-Ling Chen, Dan Peer, and Weiyi Zhang, the company operates across Shanghai, Princeton (New Jersey, US), and Rehovot (Israel). In 2024 RiboX became the first company to receive FDA IND clearance for a circular RNA therapy, RXRG001, targeting radiation-induced xerostomia and hyposalivation, and has since dosed its first patient in a Phase I/IIa trial.

Summary

RiboX Therapeutics is a Biotech company based in Shanghai, China, founded in 2021. It has raised $110.0M in total across 1 round. Investors include Qiming VP, Boehringer Ingelheim Venture Fund and Vivo Capital.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries B
$110.0M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

RiboX Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/ribox-therapeutics"><img src="https://indexed.vc/api/badge/company/ribox-therapeutics" alt="RiboX Therapeutics on Indexed.vc" width="260" height="76" /></a>